Collecting duct carcinoma of the kidney: an immunohistochemical evaluation of the use of antibodies for differential diagnosis

Human Pathology

Volumn 39, Issue 9, 2008, Pages 1350-1359

  Kobayashi, Naohito ^a   Matsuzaki, Osamu ^b   Shirai, Sumiko ^a   Aoki, Ichiro ^a   Yao, Masahiro ^a   Nagashima, Yoji ^a  

^a YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KIMITSU CHUO HOSPITAL   (Japan)

Author keywords

Collecting duct carcinoma; Immunohistochemistry; Invasive urothelial carcinoma; Papillary renal cell carcinoma

Indexed keywords

2 METHYLACYL COENZYME A RACEMASE; AGGLUTININ; BIOLOGICAL MARKER; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYTOKERATIN; NERVE CELL ADHESION MOLECULE; PROTEIN ANTIBODY; STEM CELL FACTOR; ULEX EUROPAEUS AGGLUTININ 1; UVOMORULIN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CARCINOMA IN SITU; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; KIDNEY CARCINOMA; KIDNEY COLLECTING TUBULE; KIDNEY COLLECTING TUBULE CARCINOMA; KIDNEY PAPILLA CARCINOMA; KIDNEY PELVIS; MALE; MOLECULAR WEIGHT; UROGENITAL TRACT CANCER;

ADULT; AGED; ANTIGENS, CD; CA-15-3 ANTIGEN; CADHERINS; CARCINOMA, RENAL CELL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEPRILYSIN; PEANUT AGGLUTININ; PLANT LECTINS; PROTO-ONCOGENE PROTEINS C-KIT; RACEMASES AND EPIMERASES; UROTHELIUM;

EID: 48949088315     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2007.11.020     Document Type: Article

References (31)

1. Kondo K., Yao M., Yoshida M., et al. Comprehensive mutational analysis of the VHL gene in sporadic renal cell carcinoma: relationship to clinicopathological parameters. Genes Chromosomes Cancer 34 (2002) 58-68
2. Delahunt B., and Eble J.N. Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol 10 (1997) 537-544
3. Kuroda N., Toi M., Hiroi M., and Enzan H. Review of papillary renal cell carcinoma with focus on clinical and pathobiological aspects. Histol Histopathol 18 (2003) 487-494
4. Nagashima Y. Chromophobe renal cell carcinoma. Clinical, pathological and molecular biological aspects. Pathol Int 50 (2000) 872-878
5. Tokuda N., Naito S., Matsuzaki O., Nagashima Y., Ozono S., and Igarashi T. Collecting duct (Bellini duct) renal cell carcinoma: a nation-wide survey in Japan. J Urol 176 (2006) 43-46
6. Kafe H., Verbavatz J.M., Cochand-Priollet B., Castagnet P., and Vieillefond A. Collecting duct carcinoma: an entity to be redefined?. Virchows Arch 445 (2004) 637-640
7. Srigley J.R., and Eble J.N. Collecting duct carcinoma of kidney. Semin Diagn Pathol 15 (1998) 54-67
8. Wittekind C., Greene F.L., Hutter R.V.P., Klimpfinger M., and Sobin L.H. TNM Atlas. Illustrated guide to the TNM/pTNM classification of malignant tumours. 5th ed (2005), Springer, Heidelberg, Germany 307-314
9. Srigley J.R., and Moch H. Carcinoma of the collecting ducts of Bellini. In: Eble J.N., Sauter G., Epstein J.I., and Sesterhenn I.A. (Eds). World Health Organization classification of tumours. Pathology & genetics tumours of the urinary system and male genital organs (2004), IARC Press, Lyon; France 33-34
10. Fuhrman S.A., Lasky L.C., and Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6 (1982) 655-663
11. Taki A., Nakatani Y., Misugi K., Yao M., and Nagashima Y. Chromophobe renal cell carcinoma. An immunohistochemical study of 21 Japanese cases. Mod Pathol 12 (1999) 310-317
12. Kawano N., Inayama Y., Nakaigawa N., et al. Composite distal nephron-derived renal cell carcinoma with chromophobe and collecting duct carcinomatous elements. A case report. Pathol Int 55 (2005) 360-367
13. Kuroda N., Toi M., Hiroi M., and Enzan H. Review of collecting duct carcinoma with focus on clinical and pathobiological aspects. Histol Histopathol 17 (2002) 1329-1334
14. Perez-Montiel D., Wakely P.E., Hes O., Michael M., and Suster S. High-grade urothelial carcinoma of the renal pelvis: clinicopathologic study of 108 cases with emphasis on unusual morphologic variants. Mod Pathol 19 (2006) 494-503
15. Vecchione A., Galetti T.P., Gardiman M., et al. Collecting duct carcinoma of the kidney: an immunohistochemical study of 11 cases. BMC Urol 4 (2004) 11-18
16. Skinnider B.F., Folpe A.L., Hennigar R.A., et al. Distribution of cytokeratins and vimentin in adult renal neoplasms and normal renal tissue: potential utility of a cytokeratin antibody panel in the differential diagnosis of renal tumors. Am J Surg Pathol 29 (2005) 747-754
17. Pan C.C., Chen P.C., and Ho D.M. The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases. Histopathology 45 (2004) 452-459
18. Avery A.K., Beckstead J., Renshaw A.A., and Corless C.L. Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms. Am J Surg Pathol 24 (2000) 203-210
19. Kim M.K., and Kim S. Immunohistochemical profile of common epithelial neoplasms arising in the kidney. Appl Immunohistochem Mol Morphol 10 (2002) 332-338
20. Miettinen M., and Lasota J. KIT (CD117): a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation. Appl Immunohistochem Mol Morphol 13 (2005) 205-220
21. Yamazaki K., Sakamoto M., Ohta T., Kanai Y., Ohki M., and Hirohashi S. Overexpression of KIT in chromophobe renal cell carcinoma. Oncogene 13 (2003) 847-852
22. Lin Z.H., Han E.M., Lee E.S., et al. A distinct expression pattern and point mutation of c-kit in papillary renal cell carcinomas. Mod Pathol 17 (2004) 611-616
23. Petit A., Castillo M., Santos M., Mellado B., Alcover J.B., and Mallofre C. KIT expression in chromophobe renal cell carcinoma: comparative immunohistochemical analysis of KIT expression in different renal cell neoplasms. Am J Surg Pathol 28 (2004) 676-678
24. Zigeuner R., Ratschek M., and Langner C. Kit (CD117) immunoreactivity is rare in renal cell and upper urinary tract transitional cell carcinomas. BJU Int 95 (2005) 315-318
25. Miliares D., Karasavvidou F., Papanikolaou A., and Sioutopoulou D. c-KIT expression in fetal, normal adult, and neoplastic renal tissues. J Clin Pathol 57 (2005) 463-466
26. Pan C.C., and Chen P.C.-G. A distinct expression pattern and point mutation of c-KIT in papillary renal cell carcinomas. Mod Pathol 17 (2004) 1440-1441
27. Paner G.P., Srigley J.R., Radhakrishnan A., et al. Immunohistochemical analysis of mucinous tubular and spindle cell carcinoma and papillary renal cell carcinoma of the kidney: significant immunophenotypic overlap warrants diagnostic caution. Am J Surg Pathol 30 (2006) 13-19
28. Tretiakova M.S., Sahoo S., Takahashi M., et al. Expression of alpha-methylacyl-CoA racemase in papillary renal cell carcinoma. Am J Surg Pathol 28 (2004) 69-76
29. Molinie V., Balaton A., Rotman S., et al. Alpha-methyl CoA racemase expression in renal cell carcinomas. Hum Pathol 37 (2006) 698-703
30. Amery L., Fransen M., De Nys K., Mannaerts G.P., and Van Veldhoven P.P. Mitochondrial and peroxisomal targeting of 2-methylacyl-CoA racemase in humans. J Lipid Res 41 (2000) 1752-1759
31. Ferdinandusse S., Denis S., Jist L.I., Dacremont G., Waterham H.R., and Wanders R.J. Subcellular localization and physiological role of alpha-methylacyl-CoA racemase. J Lipid Res 41 (2000) 1890-1896